Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Bock

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|July 16, 2014
[Calculation of standardised unit costs from a societal perspective for health economic evaluation]J-O Bock, C Brettschneider, H Seidl, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|May 9, 2014
[FIMA--questionnaire for health-related resource use in an elderly population: development and pilot study]H Seidl, D Bowles, J-O Bock, et al.
Journal of Musculoskeletal & Neuronal Interactions|July 14, 2007
Common musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their preventionO Bock, H Boerst, F E Thomasius, et al.
British Journal of Plastic Surgery|July 27, 2005
Genetic susceptibility to keloid disease: mutation screening of the TGFbeta3 geneA Bayat, J M Walter, O Bock, et al.
Leukemia|February 6, 2009
MPLW515L mutation in acute megakaryoblastic leukaemiaK Hussein, O Bock, K Theophile, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|June 29, 2016
[Morbidity Differences by Health Insurance Status in Old Age]A Hajek, J-O Bock, K-U Saum, et al.
Rheumatology International|September 7, 2002
Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosisJ D Ringe, H Faber, O Bock, et al.
Leukemia|July 13, 2007
Familial polycythemia vera with non-germline JAK2(V617F) mutation sparing the abnormal and clonal granulopoiesisK Hussein, O Bock, M Ballmaier, et al.
Leukemia|September 7, 2007
Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemiaG Buesche, A Ganser, B Schlegelberger, et al.
Leukemia|November 2, 2007
Chronic myeloproliferative diseases with concurrent BCR-ABL junction and JAK2V617F mutationK Hussein, O Bock, K Theophile, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|July 16, 2014
[Calculation of standardised unit costs from a societal perspective for health economic evaluation]J-O Bock, C Brettschneider, H Seidl, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|May 9, 2014
[FIMA--questionnaire for health-related resource use in an elderly population: development and pilot study]H Seidl, D Bowles, J-O Bock, et al.
Journal of Musculoskeletal & Neuronal Interactions|July 14, 2007
Common musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their preventionO Bock, H Boerst, F E Thomasius, et al.
British Journal of Plastic Surgery|July 27, 2005
Genetic susceptibility to keloid disease: mutation screening of the TGFbeta3 geneA Bayat, J M Walter, O Bock, et al.
Leukemia|February 6, 2009
MPLW515L mutation in acute megakaryoblastic leukaemiaK Hussein, O Bock, K Theophile, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|June 29, 2016
[Morbidity Differences by Health Insurance Status in Old Age]A Hajek, J-O Bock, K-U Saum, et al.
Rheumatology International|September 7, 2002
Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosisJ D Ringe, H Faber, O Bock, et al.
Leukemia|July 13, 2007
Familial polycythemia vera with non-germline JAK2(V617F) mutation sparing the abnormal and clonal granulopoiesisK Hussein, O Bock, M Ballmaier, et al.
Leukemia|September 7, 2007
Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemiaG Buesche, A Ganser, B Schlegelberger, et al.
Leukemia|November 2, 2007
Chronic myeloproliferative diseases with concurrent BCR-ABL junction and JAK2V617F mutationK Hussein, O Bock, K Theophile, et al.
Pageof 15